TPO and autoimmune thrombocytopenic purpura: Our meta-analysis demonstrated that TPO-RAs were beneficial for patients with ITP in terms of other outcomes, but the difference was not statistically significant; further, most bleeding events were mild to moderate in severity and did not increase in frequency or severity over time.